News

Lymphoid-derived dendritic cells found to shape immune suppression and allergy responses
Lymphoid-derived conventional dendritic cells (L-cDCs) may play a unique function associated with immune suppression and ...
PipelineReview.com5h
Diakonos Oncology Announces First Patient Dosed in Phase 2 Clinical Trial Evaluating DOC1021 (dubodencel) for Glioblastoma
HOUSTON, TX, USA I July 22, 2025 I Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat ...
Becker's Hospital Review6h
Immunotherapy, the new cornerstone of cancer care
From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...
News-Medical.Net7h
Radiation primes the immune system to attack lung tumors resistant to immunotherapy
By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...
News-Medical.Net8h
New insights into tick immune response could help prevent deadly virus transmission
Severe Fever with Thrombocytopenia syndrome virus (SFTSV) is a severe haemorrhagic fever virus transmitted by tick to animal ...
Radiation therapy overcomes immunotherapy resistance in some cancers
By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...
TMCnet14h
Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody® iSCIB1+
Scancell Holdings plc (AIM: SCLP), the developer of Immunobody ® and Moditope ® active immunotherapies to treat cancer, announces further positive data from the ongoing Phase 2 SCOPE trial of ...